Digital Health Startups

Ambra Health provides a cloud-based medical imaging suite that connects physicians and care staff to imaging information across the patient journey. It serves radiology groups, hospitals, and health systems, and is now part of Intelerad, a GE HealthCare company.

1 investor

The Acid Maltase Deficiency Association (AMDA) is a nonprofit organization that funds research, provides educational resources, and supports early diagnosis and care for individuals and families affected by Pompe disease, a rare genetic condition. It works with global experts, industry, and policymakers and offers webinars, peer support sessions, research grants, and patient advocacy for the Pompe disease community.

1 investor

Ameen provides at-home physiotherapy and rehabilitation services with personalized treatment plans, connecting patients with physical therapy specialists who visit their homes. It treats conditions such as neurological disorders and neck, shoulder, back, knee, and other joint pain.

1 investor

Amelio Health provides chronic pain management solutions combining clinical expertise, education, and technology for individuals, employers, insurers, and healthcare providers. The company focuses on evidence-based care to help people manage persistent pain and return to functional, productive lives.

1 investor

The American Oncology Network (AON) is a physician-led alliance supporting community oncology practices, representing physicians, nurse practitioners, and physician assistants across multiple U.S. care sites. Founded in 2018, it provides practice management services so oncology physicians can focus on patient care.

1 investor

Ameriprohealthis an emergency medical transport and response service that provides rapid patient transfers, hospital discharge coordination, and medical transport for scheduled visits.

1 investor

Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.

1 investor

AMGA Foundation is a nonprofit organization that brings together medical groups, health systems, and providers to address public health challenges through population health initiatives and quality improvement programs. It develops evidence-based best practices for managing chronic conditions, preventing illnesses, and improving healthcare outcomes for millions of patients across the United States.

1 investor

AMHC is a Certified Community Behavioral Health Clinic providing integrated mental health and substance use treatment services across a three-county region in Maine. Operating 27 locations with 350+ employees, the organization annually serves approximately 5,500 clients through comprehensive programs addressing mental health, addiction, crisis support, and related behavioral healthcare needs.

1 investor

AMI (Acute Medical Innovation) develops medical device hardware and software-as-a-medical-device (SaMD) to redefine stethoscope-based auscultation, including the Cardio-EGG (AMI-SSS01 series phonocardiography device) that simultaneously captures heart sounds and ECG. Using deep learning and other machine learning models trained on clinical data, it builds diagnostic-assist tools for heart disease and a telemedicine support system called "Cloud Choshin" for sharing heart sound, ECG, and analysis results.

1 investor

Amicare connects families with vetted home care providers for aging in place and personalized care needs. The platform streamlines matching between care seekers and trusted caregivers to address gaps in accessible, flexible home care services.

1 investor

AMILI is a precision gut microbiome company that offers at-home stool test kits analyzing gut bacteria and provides personalized nutrition, lifestyle, and probiotic recommendations with dedicated nutritionists. It serves consumers, clinicians, and researchers, maintaining a multi-ethnic Asian microbiome database, with direct-to-consumer orders in Singapore and partner clinics across Southeast Asia.

1 investor

Amilis is a women's health platform that unifies patient medical history, clinical workflows, and treatment pathways into a single longitudinal record shared between patients and clinicians. It serves women seeking care as well as gynaecologists and fertility specialists across areas such as IVF, fertility, PCOS, endometriosis, and menopause.

1 investor

AMIRA-Welt is an education and community platform for German pharmacy staff (PTA, PKA, PhiP and pharmacists), offering professional courses via its academy and campus, a magazine, surveys, and a subscription "AMIRA-Box" with OTC product samples to test. Membership is free and aimed at local pharmacy teams; the platform also serves partner brands and manufacturers.

1 investor

AMLo Biosciences develops prognostic and companion diagnostic tests for cancer patients, initially focusing on melanoma and oropharyngeal squamous cell carcinoma. The company translates cancer biomarker research into tests designed to stratify patient risk and optimize treatment allocation.

1 investor

A nonprofit that trains, funds, and equips local organizations and frontline humanitarian workers to deliver trauma- and identity-informed mental health and psychosocial support to displaced people. Its programs serve communities affected by conflict and displacement, including children in Lebanon, frontline workers in Gaza, and Afghan women.

1 investor

Amoy Diagnostics develops molecular diagnostic test kits for cancer detection, including PCR, IHC, FISH, and next-generation sequencing products that detect gene mutations such as PIK3CA, KRAS, NRAS, BRAF, and IDH1, as well as microsatellite instability. Its products serve clinical and oncology diagnostics and include related nucleic acid extraction reagents and instruments.

1 investor

Ampa Health develops a transcranial magnetic stimulation (TMS) system designed to strengthen the brain's circuits for resilience and neural change. Its clinician-built platform is aimed at mental health care providers delivering TMS treatment.

1 investor

Amplifai develops an AI-powered platform (TFscan) that detects diabetic foot complications in real time to support clinical decision-making and prevent amputations. The system integrates with hospital and clinic infrastructure to provide risk scores and analytics for patient care teams.

1 investor

Amplitude VC creates, builds, and grows companies specializing in precision medicine to transform patient outcomes. The firm invests from ideation through patient care, focusing on innovations in human health.

1 investor

Amprion offers SAAmplify-αSYN, a clinically validated diagnostic test that detects misfolded (pathological) α-synuclein in cerebrospinal fluid to aid diagnosis of neurodegenerative disorders such as Parkinson's disease, Lewy body dementia, and Alzheimer's. The seed amplification assay is aimed at physicians and researchers, providing biology-based evidence to support diagnosis of mixed neurodegenerative pathologies.

1 investor

Amprion develops and offers SAAmplify-αSYN, a validated diagnostic test that detects misfolded pathological α-synuclein in cerebrospinal fluid to support the diagnosis of neurodegenerative disorders such as Parkinson's, Lewy body dementia, and Alzheimer's. It serves physicians and researchers seeking biological confirmation of neurodegenerative disease.

1 investor

AMPS provides cost management solutions for self-insured employers, focusing on member experience and expense optimization.

1 investor

A drug discovery company focused on medicinal chemistry and preclinical research across multiple therapeutic areas.

1 investor